Please login to the form below

PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international pharmaceutical and biotechnology companies today.

Our tailored services include strategic market access, landscape assessments, payer and KOL engagement, value propositions, GVDs, evidence generation, real-world evidence, pricing and reimbursement strategy.

Quality is at the heart of every engagement we deliver. We pride ourselves on providing pragmatic and insightful solutions that are informed and validated by a global network of over 700 advisors from 18 countries. We are an experienced, highly educated, multidisciplinary team with broad disease area backgrounds and extensive, practical market access knowledge.

Our experience encompasses a wide range of indications, including; cardiovascular and renal, gastroenterology, immunology, infectious diseases and vaccines, metabolism and endocrinology, neurology and psychiatry, oncology/hematology, ophthalmology, rare diseases, reproductive, and urology.

In collaboration with leading pharmaceutical organizations, we have developed a suite of digital applications that transform market access processes. These dynamic applications enable clients to unlock and optimize product value from early development through to successful country submissions.

“I wanted to thank you for the very thorough, high quality, and tremendously useful piece of work you have completed. There is a lot to digest. This is what I call ‘value for money’.”
Global reimbursement Director, top-20 pharmaceutical company

“The HTA submissions produced using the PRMA Navigator® saved us weeks. The robust content provided a high quality first draft and provided a more focused source than the GVD, targeted to our country-specific needs.”
Country market access manager, top-10 pharmaceutical company

Press Releases

Transforming value and access outcomes in the Asia-Pacific region: a new market access study

A leading pharmaceutical manufacturer adopted digital technology to transform processes and drive optimal market access for their Phase 2 and 3 products. This study summarizes the key challenges, the solutions, and the value gained by the manufacturer.

Five new case studies describe how top-10 manufacturers have transformed their market access processes
Drive payer submission readiness for your Phase 2 and 3 products

PRMA Healthcheck® late module celebrates over 40 readiness assessments successfully delivered and announces a new version release.

White Papers and Resources

Digital applications are transforming the market access landscape

Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy.

Achieve up to 80% auto-population of your first draft HTA submission

Videos

Latest Tweets

Company Details

PRMA Consulting Ltd

+44 (0)1252 786284

Contact Website

Address:
Linea House
Harvest Crescent
Ancells Business Park
Fleet
GU51 2UZ
United Kingdom

Latest content on this profile

Transforming value and access outcomes in the Asia-Pacific region: a new market access study
A leading pharmaceutical manufacturer adopted digital technology to transform processes and drive optimal market access for their Phase 2 and 3 products. This study summarizes the key challenges, the solutions, and the value gained by the manufacturer.
PRMA Consulting Ltd
Five new case studies describe how top-10 manufacturers have transformed their market access processes

PRMA Consulting Ltd
Transforming the market access landscape with digital applications
Pharmaceutical and biotechnology companies are turning to technology more frequently to solve business issues, and are increasingly using digital technology to optimize market access for their products.Read the article >>  https://www.prmaconsulting.com/digital_applications_whitepaper/index.html?utm_source=PMLiVE&utm_medium=HubArticle&utm_campaign=DigitalTransThis new article helps you to:appreciate why digital applications are transforming the value and access functionsunderstand how new technology is informing direction and becoming an essential enabler in realizing visiongain insight into considerations for re-evaluating your technology and your suppliers.
PRMA Consulting Ltd
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy.
PRMA Consulting Ltd
Achieve up to 80% auto-population of your first draft HTA submission

PRMA Consulting Ltd
Video: Drive payer submission readiness for your Phase 2 and 3 products
Transform your market access processes with the PRMA Healthcheck®  late module. The digital application encourages collaboration with integrated decision-making between affiliate and global functions to build an evidence generation plan. Efficiency is increased through the systematic assessment of payer evidence readiness for your product against actual submission template requirements with a visual heatmap. An organizational vision and action plan to anticipate and mitigate value challenges to optimize payer readiness.
PRMA Consulting Ltd